Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Aptevo Therapeutics (NASDAQ:APVO) reported its Q1 earnings results on Thursday, May 12, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

MeiraGTx Hldgs: Q1 Earnings Insights

MeiraGTx Hldgs (NASDAQ:MGTX) reported its Q1 earnings results on Thursday, May 12, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

BridgeBio Inks Licensing Pact With Bristol Myers For SHP2 Inhibitor In Oncology

BridgeBio Pharma Inc (NASDAQ:BBIO) has announced an exclusive license with Bristol Myers Squibb Co (NYSE:BMY) to develop and commercialize BBP-398, a potentially best-in-class SHP2 inhibitor, in oncology. Under the agreement terms, BridgeBio will receive an upfront payment of $90 million, up to $815 million in development, regulatory and sales milestone payments, and tiered royalties in…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Recap: Artelo Biosciences Q2 Earnings

Artelo Biosciences (NASDAQ:ARTL) reported its Q2 earnings results on Thursday, May 12, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Harbor Custom Dev Q1 Earnings

Harbor Custom Dev (NASDAQ:HCDI) reported its Q1 earnings results on Thursday, May 12, 2022 at 08:30 AM. Here's what investors need to know about the announcement.

Benzinga

Indaptus Therapeutics: Q1 Earnings Insights

Indaptus Therapeutics (NASDAQ:INDP) reported its Q1 earnings results on Thursday, May 12, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Immunome: Q1 Earnings Insights

Immunome (NASDAQ:IMNM) reported its Q1 earnings results on Thursday, May 12, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Recap: Entera Bio Q1 Earnings

Entera Bio (NASDAQ:ENTX) reported its Q1 earnings results on Thursday, May 12, 2022 at 08:30 AM. Here's what investors need to know about the announcement.

Benzinga

10x Genomics: Q1 Earnings Insights

10x Genomics (NASDAQ:TXG) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Benzinga

Recap: PureCycle Technologies Q1 Earnings

PureCycle Technologies (NASDAQ:PCT) reported its Q1 earnings results on Thursday, May 12, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Radcom: Q1 Earnings Insights

Radcom (NASDAQ:RDCM) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Olink Holding Q1 Earnings

Olink Holding (NASDAQ:OLK) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Zealand Pharma Q1 Earnings

Zealand Pharma (NASDAQ:ZEAL) reported its Q1 earnings results on Thursday, May 12, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Knightscope Bags Its First Las Vegas Casino Contract

Security technology company Knightscope, Inc. (NASDAQ:KSCP) signed its first Las Vegas casino client. Financial terms were not disclosed. KSCP noted a leading U.S.-based casino and gaming facility operator with over a dozen locations across the country had purchased its first Knightscope Autonomous Security Robot (ASR) to boost its security and surveillance program. Knightscope’s…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

NGM Bio Initiates NGM438 Phase 1/1b trial for advanced solid tumors

NGM Biopharmaceuticals, Inc. (NGM Bio) (NASDAQ: NGM) initiated a Phase 1/1b clinical study of its drug candidate NGM438 for the treatment of patients with advanced solid tumors.

Benzinga

RADCOM Shares Gain On Q1 Beat, Guidance Boost

RADCOM Ltd (NASDAQ:RDCM) reported first-quarter FY22 revenue growth of 16% year-on-year to $10.6 million, ahead of the consensus of $10.2 million. The non-GAAP gross margin contracted 100 bps to 74% as the costs expanded 19.9% Y/Y. Non-GAAP EPS of $0.04 beat the consensus loss of $(0.04). RADCOM held $70.9 million in cash and…

Benzinga

Cathie Wood Puts In Another $29M In Coinbase, Showing Conviction In Crypto Stock Amid Sell-Off

Cathie Wood-led Ark Investment Management on Wednesday further raised its exposure in Coinbase Global Inc (NASDAQ: COIN) on the day shares of the cryptocurrency exchange crashed after it reported a first-quarter loss and a significant drop in trading volume.

Benzinga

Crypto Billionaires See Wealth Eroded With This Week's Market Crash

The billionaire CEOs of major crypto exchanges saw their personal fortunes diminish as Bitcoin (CRYPTO: BTC) and the wider crypto market extended losses this week.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

What's Driving Rivian Stock Lower Today?

Rivian Automotive Inc (NASDAQ: RIVN) shares are trading lower Thursday after the company reported financial results. Several analysts lowered price targets on the stock following the company's quarterly results.

Benzinga

Flora Growth's Vessel And JustCBD Make Moves In Canada And UK, Here Are The Details

Flora Growth Corp.’s (NASDAQ: FLGC) Vessel and JustCBD brands revealed new developments.

Benzinga

The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Why Beyond Meat Shares Are Falling

Beyond Meat Inc (NASDAQ: BYND) shares are trading lower Thursday after the company reported worse-than-expected financial results.

Benzinga

Apyx Medical: Q1 Earnings Insights

Apyx Medical (NASDAQ:APYX) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

vTv Therapeutics: Q1 Earnings Insights

vTv Therapeutics (NASDAQ:VTVT) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:45 AM. Here's what investors need to know about the announcement.

Benzinga

Akouos: Q1 Earnings Insights

Akouos (NASDAQ:AKUS) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

1 … 507 508 509 510

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Ark Investment Management

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.